32
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Levels of calprotectin (leukocyte L1 protein) during apheresis

, &
Pages 479-482 | Received 02 Dec 1991, Accepted 25 Jan 1992, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hilde Berner Hammer, Sigve Lans Pedersen, Maria K. Jonsson, Linda Mathsson-Alm, Isabel Gehring, Joe Sexton, Espen A. Haavardsholm & Johan Askling. (2023) Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods. Scandinavian Journal of Clinical and Laboratory Investigation 83:5, pages 330-335.
Read now

Articles from other publishers (3)

Andrew G. Turner, Cheryl-lynn Y. Ong, Mark J. Walker, Karrera Y. Djoko & Alastair G. McEwan. 2017. Microbiology of Metal Ions. Microbiology of Metal Ions 123 191 .
G. Hetland, G. J. Talgo & M. K. Fagerhol. (1998) Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. Molecular Pathology 51:3, pages 143-148.
Crossref
B Johne, M K Fagerhol, T Lyberg, H Prydz, P Brandtzaeg, C F Naess-Andresen & I Dale. (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin.. Molecular Pathology 50:3, pages 113-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.